ClinicalTrials.gov
ClinicalTrials.gov Menu

Rapamycin in Relapsed Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00874562
Recruitment Status : Completed
First Posted : April 2, 2009
Last Update Posted : November 23, 2016
Sponsor:
Collaborators:
Brigham and Women's Hospital
Boston Children’s Hospital
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Lewis B. Silverman, M.D., Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : April 2016